Anavo Therapeutics: Funding, Investors & Team (Sep 2026)
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications
Anavo Therapeutics has raised $33.5M across 2 funding rounds on record, the most recent a Seed of $9.4M announced in May 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Anavo Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2023.
Anavo Therapeutics Funding Rounds
Anavo Therapeutics raised $24.1M in a Seed announced in Apr 2021.
2.1 years later, a Seed of $9.4M was announced in May 2023.
Anavo Therapeutics Founders and Leadership Team
Contact details for the Anavo Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Anavo Therapeutics Funding Compared to Other Biotechnology Startups
Anavo Therapeutics' latest round of $9.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Anavo Therapeutics in Biotechnology and Leiden
Companies Similar to Anavo Therapeutics
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Anavo Therapeutics Funding FAQs
What does Anavo Therapeutics do?
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications
How much funding has Anavo Therapeutics raised?
Anavo Therapeutics has raised $33.5M across 2 rounds on record. The most recent is a Seed of $9.4M announced in May 2023.
When did Anavo Therapeutics last raise funding?
Anavo Therapeutics' most recent funding round on record is a Seed of $9.4M, announced in May 2023.
Who is the CEO of Anavo Therapeutics?
Birgit Zech is listed as CEO at Anavo Therapeutics.
Where is Anavo Therapeutics headquartered?
Anavo Therapeutics is based in Leiden, Zuid-Holland, Netherlands.
How many employees does Anavo Therapeutics have?
Anavo Therapeutics is in the 1-10 employee band.
How does Anavo Therapeutics' funding compare to other Biotechnology startups?
Anavo Therapeutics' latest round of $9.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Anavo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Anavo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.